MLKL and neoplasm: These results further indicate that necroptosis most likely does not contribute to tumor initiation and progression in BrafV600EPten−/−-driven melanoma, in contrast to many other solid tumors that rely on MLKL-dependent cell death to promote tumor growth and metastasis [44].